Literature DB >> 25957294

Role of macrophage migration inhibitory factor in age-related lung disease.

Maor Sauler1, Richard Bucala2, Patty J Lee3.   

Abstract

The prevalence of many common respiratory disorders, including pneumonia, chronic obstructive lung disease, pulmonary fibrosis, and lung cancer, increases with age. Little is known of the host factors that may predispose individuals to such diseases. Macrophage migration inhibitory factor (MIF) is a potent upstream regulator of the immune system. MIF is encoded by variant alleles that occur commonly in the population. In addition to its role as a proinflammatory cytokine, a growing body of literature demonstrates that MIF influences diverse molecular processes important for the maintenance of cellular homeostasis and may influence the incidence or clinical manifestations of a variety of chronic lung diseases. This review highlights the biological properties of MIF and its implication in age-related lung disease.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  MIF; innate immunity; lung

Mesh:

Substances:

Year:  2015        PMID: 25957294      PMCID: PMC4491511          DOI: 10.1152/ajplung.00339.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  159 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice.

Authors:  Kechun Tang; Harry B Rossiter; Peter D Wagner; Ellen C Breen
Journal:  J Appl Physiol (1985)       Date:  2004-06-18

3.  Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness.

Authors:  A Beishuizen; L G Thijs; C Haanen; I Vermes
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

4.  Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells.

Authors:  Shunsuke Minagawa; Jun Araya; Takanori Numata; Satoko Nojiri; Hiromichi Hara; Yoko Yumino; Makoto Kawaishi; Makoto Odaka; Toshiaki Morikawa; Stephen L Nishimura; Katsutoshi Nakayama; Kazuyoshi Kuwano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-17       Impact factor: 5.464

5.  Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha.

Authors:  J M Daun; J G Cannon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

6.  Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.

Authors:  Heng Ma; Jingying Wang; D Paul Thomas; Chao Tong; Lin Leng; Wenkui Wang; Melanie Merk; Swen Zierow; Jürgen Bernhagen; Jun Ren; Richard Bucala; Ji Li
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

7.  Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.

Authors:  Christin E Burd; Jessica A Sorrentino; Kelly S Clark; David B Darr; Janakiraman Krishnamurthy; Allison M Deal; Nabeel Bardeesy; Diego H Castrillon; David H Beach; Norman E Sharpless
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

8.  Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.

Authors:  Diana Starlets; Yael Gore; Inbal Binsky; Michal Haran; Nurit Harpaz; Lev Shvidel; Shirly Becker-Herman; Alain Berrebi; Idit Shachar
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

9.  The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.

Authors:  Sachin Yende; Derek C Angus; Lan Kong; John A Kellum; Lisa Weissfeld; Robert Ferrell; David Finegold; Melinda Carter; Lin Leng; Zhi-Yong Peng; Richard Bucala
Journal:  FASEB J       Date:  2009-04-03       Impact factor: 5.191

10.  Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.

Authors:  Thorsten Hagemann; Stephen C Robinson; Richard G Thompson; Kellie Charles; Hagen Kulbe; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

View more
  17 in total

Review 1.  Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.

Authors:  Mauricio Rojas; Ana L Mora; Maria Kapetanaki; Nathaniel Weathington; Mark Gladwin; Oliver Eickelberg
Journal:  Ann Am Thorac Soc       Date:  2015-12

2.  A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity.

Authors:  C Zhang; C Ramsey; A Berical; L Yu; L Leng; K A McGinnis; Y Song; H Michael; M C McCormack; H Allore; A Morris; K Crothers; R Bucala; P J Lee; M Sauler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-12-06       Impact factor: 5.464

Review 3.  Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace.

Authors:  Louise Hecker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

4.  Pro-Inflammatory and Pro-Fibrogenic Effects of Ionic and Particulate Arsenide and Indium-Containing Semiconductor Materials in the Murine Lung.

Authors:  Wen Jiang; Xiang Wang; Olivia J Osborne; Yingjie Du; Chong Hyun Chang; Yu-Pei Liao; Bingbing Sun; Jinhong Jiang; Zhaoxia Ji; Ruibin Li; Xiangsheng Liu; Jianqin Lu; Sijie Lin; Huan Meng; Tian Xia; André E Nel
Journal:  ACS Nano       Date:  2017-02-08       Impact factor: 15.881

5.  Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma.

Authors:  Tarek Z El-Adly; Sally Kamal; Hala Selim; Shahira Botros
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

6.  HO-1 Is Essential for Tetrahydroxystilbene Glucoside Mediated Mitochondrial Biogenesis and Anti-Inflammation Process in LPS-Treated RAW264.7 Macrophages.

Authors:  Weihua Yu; Xiaodi Zhang; Hao Wu; Qingbiao Zhou; Zhao Wang; Rui Liu; Jiangzheng Liu; Xin Wang; Chunxu Hai
Journal:  Oxid Med Cell Longev       Date:  2017-04-03       Impact factor: 6.543

7.  Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation.

Authors:  Amanda S Pellowe; Maor Sauler; Yue Hou; Jonathan Merola; Rebecca Liu; Brenda Calderon; Holly M Lauridsen; Mariah R Harris; Lin Leng; Yi Zhang; Pathricia V Tilstam; Jordan S Pober; Richard Bucala; Patty J Lee; Anjelica L Gonzalez
Journal:  FASEB J       Date:  2018-09-25       Impact factor: 5.834

8.  Models for preclinical studies in aging-related disorders: One is not for all.

Authors:  Gaetano Santulli; Consuelo Borras; Jean Bousquet; Laura Calzà; Antonio Cano; Maddalena Illario; Claudio Franceschi; Giuseppe Liotta; Marcello Maggio; William D Molloy; Nunzia Montuori; Rónán O'Caoimh; Francesc Orfila; Amelia P Rauter; Aurelia Santoro; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2016-01-31

9.  Proteomic Analysis Shows Constitutive Secretion of MIF and p53-associated Activity of COX-2-/- Lung Fibroblasts.

Authors:  Mandar Dave; Abul B M M K Islam; Roderick V Jensen; Agueda Rostagno; Jorge Ghiso; Ashok R Amin
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-12-13       Impact factor: 7.691

10.  Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum.

Authors:  Oscar Illescas; Juan C Gomez-Verjan; Lizbeth García-Velázquez; Tzipe Govezensky; Miriam Rodriguez-Sosa
Journal:  Front Genet       Date:  2018-03-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.